Front Page

Some of the UK’s most ambitious early-stage life science companies are choosing Victoria House as their London base, adding fresh momentum to one of the capital’s most exciting life science communities. Developed by Oxford Properties and Pioneer Group, the Bloomsbury Square building has attracted 24 innovative organisations since it launched last...

Family-owned company Salts Healthcare is celebrating the launch of Salts Australia and New Zealand. Having recently grown its turnover and market share in the UK and Europe, the Birmingham-based business now has international offices and operations across all five continents. Peter Salt, Salts Healthcare group chairman said, “After successfully working...

Medilink Midlands continues to address one of the sector’s most pressing challenges: developing the next generation of work-ready talent for life sciences and medtech.  The Future Talent Laboratory (FTL) pilot programme, delivered in partnership with the University of Warwick (UoW) and Anglia Ruskin University (ARU), connects students and early-career researchers with...

MediWales will be holding their annual Connects conference on the 18th June at the All Nations Centre, Cardiff. NHS colleagues from across Wales, local companies and the wider industry sector will join to share clinical innovation in practice to improve patient outcomes. The event includes presentations, workshops, exhibitions and networking....

A New Chapter In Central Oxford Pioneer has secured planning permission for a new 100,000 sq ft workspace at 1-12 Magdalen Street, delivered in partnership with The Crown Estate and Oxford Science Enterprises. Positioned in the heart of the city, the scheme will reimagine the former Debenhams building as a...

New parliamentary scrutiny of the UK’s innovation landscape has reinforced longstanding concerns about how investment in innovation is distributed across the country, with Pioneer Group, a specialist in technology infrastructure and venture building, urging swift action to address persistent barriers to research commercialisation. The Science, Innovation and Technology Committee’s report...

130 leaders gather as part of Leicestershire Innovation Festival Charnwood Campus and Midlands Medilink stage day of impactful speakers Industry leaders, investors and innovators queue up to deliver insights at sell-out summit More than 130 industry leaders, investors and innovators gathered at Charnwood Campus for a major conference focused on...

The University of Nottingham has played host to the launch of a new programme to help East Midlands researchers commercialise life-changing treatments. SPARK The Midlands, the first UK branch of Stanford University's prestigious global SPARK programme – the global pre-clinical accelerator programme with a presence in more than 50 locations...

Upperton has formally submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for approval of its 7,000 sq. ft sterile manufacturing facility. This submission follows the successful completion of aseptic process simulation (APS) validation batches executed under the stringent requirements of the revised EU GMP Annex...

At a glance: Company: SurePulse Sector: MedTech / Neonatal Care MeTAP support accessed: Grant funding, clinical simulation coordination, neonatal expertise, video capture and advisory support Key outcome: Workflow validation of SurePulse NeoPatch, quantifiable efficiency gains, regulatory progression support The challenge: SurePulse is developing SurePulse NeoPatch, a wireless, multi-parameter neonatal monitoring...